38 related articles for article (PubMed ID: 24854401)
1. Regional Lymph Node Uptake of [(18)F]Fluorodeoxyglucose After Definitive Chemoradiation Therapy Predicts Local-Regional Failure of Locally Advanced Non-Small Cell Lung Cancer: Results of ACRIN 6668/RTOG 0235.
Markovina S; Duan F; Snyder BS; Siegel BA; Machtay M; Bradley JD
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):597-605. PubMed ID: 26461002
[TBL] [Abstract][Full Text] [Related]
2. Primary tumor standardized uptake value measured on F18-Fluorodeoxyglucose positron emission tomography is of prediction value for survival and local control in non-small-cell lung cancer receiving radiotherapy: meta-analysis.
Na F; Wang J; Li C; Deng L; Xue J; Lu Y
J Thorac Oncol; 2014 Jun; 9(6):834-42. PubMed ID: 24787963
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity analysis of FDG PET tumor voxel cluster radiomics and dosimetry for predicting mid-chemoradiation regional response of locally advanced lung cancer.
Duan C; Chaovalitwongse WA; Bai F; Hippe DS; Wang S; Thammasorn P; Pierce LA; Liu X; You J; Miyaoka RS; Vesselle HJ; Kinahan PE; Rengan R; Zeng J; Bowen SR
Phys Med Biol; 2020 Oct; 65(20):205007. PubMed ID: 33027064
[TBL] [Abstract][Full Text] [Related]
4. Does Tumor FDG-PET Avidity Represent Enhanced Glycolytic Metabolism in Non-Small Cell Lung Cancer?
Kernstine KH; Faubert B; Do QN; Rogers TJ; Hensley CT; Cai L; Torrealba J; Oliver D; Wachsmann JW; Lenkinski RE; Malloy CR; Deberardinis RJ
Ann Thorac Surg; 2020 Apr; 109(4):1019-1025. PubMed ID: 31846640
[TBL] [Abstract][Full Text] [Related]
5. Treatment Response to Neoadjuvant Therapy in Squamous Esophageal Cancer-Correlation Between Metabolic Response and Histopathology.
Kaderi ASA; Sabita J; Tiwari VK; Pawar A; Niyogi D
J Gastrointest Cancer; 2024 Feb; ():. PubMed ID: 38308686
[TBL] [Abstract][Full Text] [Related]
6. Correlation between 18-FDG standardized uptake value and tumor grade in patients with resectable non-small cell lung cancer.
Kużdżał B; Moszczyński K; Żanowska K; Hauer J; Popovchenko S; Bryndza M; Warmus J; Trybalski Ł; Rudnicka L; Kocoń P
Transl Cancer Res; 2023 Dec; 12(12):3530-3537. PubMed ID: 38192987
[TBL] [Abstract][Full Text] [Related]
7. Patient-Reported Outcomes as Interradiographic Predictors of Response in Non-Small Cell Lung Cancer.
Bhatt AS; Schabath MB; Hoogland AI; Jim HSL; Brady-Nicholls R
Clin Cancer Res; 2023 Aug; 29(16):3142-3150. PubMed ID: 37233986
[TBL] [Abstract][Full Text] [Related]
8. Intrapatient variability of 18F-FDG uptake in normal tissues.
Sayed MHM; Abdelnaim AK; Mohamadien NR
J Clin Imaging Sci; 2022; 12():37. PubMed ID: 36128350
[TBL] [Abstract][Full Text] [Related]
9. Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study.
Sollini M; Morbelli S; Ciccarelli M; Cecconi M; Aghemo A; Morelli P; Chiola S; Gelardi F; Chiti A
Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3187-3197. PubMed ID: 33677642
[TBL] [Abstract][Full Text] [Related]
10. IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy.
Travis WD; Dacic S; Wistuba I; Sholl L; Adusumilli P; Bubendorf L; Bunn P; Cascone T; Chaft J; Chen G; Chou TY; Cooper W; Erasmus JJ; Ferreira CG; Goo JM; Heymach J; Hirsch FR; Horinouchi H; Kerr K; Kris M; Jain D; Kim YT; Lopez-Rios F; Lu S; Mitsudomi T; Moreira A; Motoi N; Nicholson AG; Oliveira R; Papotti M; Pastorino U; Paz-Ares L; Pelosi G; Poleri C; Provencio M; Roden AC; Scagliotti G; Swisher SG; Thunnissen E; Tsao MS; Vansteenkiste J; Weder W; Yatabe Y
J Thorac Oncol; 2020 May; 15(5):709-740. PubMed ID: 32004713
[TBL] [Abstract][Full Text] [Related]
11. Quantitative imaging biomarkers in nuclear medicine: from SUV to image mining studies. Highlights from annals of nuclear medicine 2018.
Sollini M; Bandera F; Kirienko M
Eur J Nucl Med Mol Imaging; 2019 Dec; 46(13):2737-2745. PubMed ID: 31690962
[TBL] [Abstract][Full Text] [Related]
12. Gross handling of pulmonary resection specimen: maintaining the 3-dimensional orientation.
Radonic T; Dickhoff C; Mino-Kenudson M; Lely R; Paul R; Thunnissen E
J Thorac Dis; 2019 Jan; 11(Suppl 1):S37-S44. PubMed ID: 30775026
[TBL] [Abstract][Full Text] [Related]
13. An investigation of the relation between tumor-to-liver ratio (TLR) and tumor-to-blood standard uptake ratio (SUR) in oncological FDG PET.
Hofheinz F; Bütof R; Apostolova I; Zöphel K; Steffen IG; Amthauer H; Kotzerke J; Baumann M; van den Hoff J
EJNMMI Res; 2016 Dec; 6(1):19. PubMed ID: 26936768
[TBL] [Abstract][Full Text] [Related]
14. Metabolic activity measured by FDG PET predicts pathological response in locally advanced superior sulcus NSCLC.
Bahce I; Vos CG; Dickhoff C; Hartemink KJ; Dahele M; Smit EF; Boellaard R; Hoekstra OS; Thunnissen E
Lung Cancer; 2014 Aug; 85(2):205-12. PubMed ID: 24854401
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
[TBL] [Abstract][Full Text] [Related]
16. Are pretreatment 18F-FDG PET tumor textural features in non-small cell lung cancer associated with response and survival after chemoradiotherapy?
Cook GJ; Yip C; Siddique M; Goh V; Chicklore S; Roy A; Marsden P; Ahmad S; Landau D
J Nucl Med; 2013 Jan; 54(1):19-26. PubMed ID: 23204495
[TBL] [Abstract][Full Text] [Related]
17. Ratio of standardized uptake value on PET helps predict response and outcome after chemotherapy in advanced non-small cell lung cancer.
Kaira K; Endo M; Asakura K; Tsuya A; Nakamura Y; Naito T; Murakami H; Takahashi T; Yamamoto N
Ann Nucl Med; 2010 Dec; 24(10):697-705. PubMed ID: 20824397
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic implications of molecular imaging with PET in the combined modality treatment of lung cancer.
van Loon J; van Baardwijk A; Boersma L; Ollers M; Lambin P; De Ruysscher D
Cancer Treat Rev; 2011 Aug; 37(5):331-43. PubMed ID: 21320756
[TBL] [Abstract][Full Text] [Related]
19. Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project.
Berghmans T; Dusart M; Paesmans M; Hossein-Foucher C; Buvat I; Castaigne C; Scherpereel A; Mascaux C; Moreau M; Roelandts M; Alard S; Meert AP; Patz EF; Lafitte JJ; Sculier JP;
J Thorac Oncol; 2008 Jan; 3(1):6-12. PubMed ID: 18166834
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
